N/A
Completed N=244
Hispanic Men Building Respect Education and Safety/ HoMBRES Manteniendo Respeto, Educacion y Seguridad.
Substance Abuse · Domestic Violence · HIV
Source: ClinicalTrials.gov NCT03730987 ↗
Enrolled (actual)
244
Serious AEs
0.0%
Results posted
Oct 2022
Primary outcomePrimary: Number of Participant Fathers Self-reporting Engagement in Risky Sexual Behaviors — 42; 38; 38; 53 Participants
Summary
The overall objective of this project is to adapt and enhance HoMBReS (Hispanic Men Building Respect, Education, and Safety within Families /Hombres Manteniendo Respeto, Educacion y Seguridad de Familia), a Center for Disease Control (CDC)-identified best-evidence HIV behavioral intervention designed to reduce substance abuse, family violence, and HIV/AIDS (SAVA) among sexually active heterosexual Latino seasonal farmworkers (LSFWs) in rural areas.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participant Fathers Self-reporting Engagement in Risky Sexual Behaviors |
42; 38; 38; 53 | — |
| PRIMARY The Number of Participant Fathers Self-reporting Experiences of Intra-partner Violence |
10; 9; 10; 5 | — |
| PRIMARY The Number of Days Participant Fathers Reported Drinking in the Past 90 Days. |
8.59; 6.72; 11.08; 8.48 | — |
| PRIMARY HIV Knowledge as Measured by the Brief HIV Knowledge Questionnaire |
0.65; 0.65; 0.81; 0.69 | — |
| PRIMARY HIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV Scale |
38.30; 38.80; 40.20; 38.50 | — |
| PRIMARY The Number of Drinks Per Day Over the Past 90 Days. |
2.82; 2.35; 2.89; 3.06 | — |
| SECONDARY Level of Self-reported Communication With Son as Measured by the Parental Practicing Scale |
4.1; 4.3; 3.41; 3.36; 4.2; 4.4 | — |
Eligibility Criteria
Inclusion Criteria
- male
- adults (age 18 or above)
- living in semirural and urban areas of Miami Dade
- Latino
- understand and speaks Spanish
- has an eligible son ( 11-17 years old)
Exclusion Criteria
- father does not provide consent and permission for his son
- son does not provide assent
Data sourced from ClinicalTrials.gov (NCT03730987). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.